Clinical Trial Update: A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating NN1952 was conducted in healthy subjects and in individuals with Type 1 and Type 2 diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NN1952

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED